DexCom, Inc. (DXCM)
NASDAQ
91.06
-1.28 (-1.39%)
Closed
Aug 24, 2026
Day's Range
91.0492.58
52 wk Range
54.1192.58
Financial Statements - DXCM - DexCom, Inc.
Revenue
4.66B▲ 15.6%
Net Income
836.30M▲ 45.1%Net Margin 17.9%
EBITDA
1.35B▲ 43.7%
Free Cash Flow
1.07B▲ 70.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.66B | 4.03B | 3.62B | 2.90B | 2.44B | 1.92B |
| Cost of Goods | 1.86B | 1.59B | 1.33B | 1.02B | 768M | 646.60M |
| Gross Profit | 2.80B | 2.43B | 2.28B | 1.88B | 1.68B | 1.28B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 911.80M | 600M | 597.70M | 391.20M | 265.80M | 299.50M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 82.20M | -6.20M | -2M | -5.60M | 8.10M | -5.90M |
| Pre Tax Income | 1.08B | 709M | 710.40M | 390.80M | 256.80M | 225M |
| Income Tax | 252.10M | 132.80M | 168.90M | 49.60M | 39.90M | -268.60M |
| Net Income | 836.30M | 576.20M | 541.50M | 341.20M | 216.90M | 493.60M |
| EPS Basic | 2.14 | 1.46 | 1.4 | 0.88 | 0.4 | 1.3075 |
| EPS Diluted | 2.09 | 1.42 | 1.3 | 0.82 | 0.3875 | 1.265 |
| Basic Shares Outstanding | 390.20M | 393.60M | 386M | 389.40M | 386.80M | 377.60M |
| Diluted Shares Outstanding | 390.20M | 393.60M | 386M | 389.40M | 386.80M | 377.60M |
| Ebit | 1.10B | 728M | 730.70M | 409.40M | 275.60M | 309.70M |
| Ebitda | 1.35B | 945.70M | 916.70M | 565.30M | 377.70M | 382.70M |
| Net Income Continuous Operations | 836.30M | 576.20M | 541.50M | 341.20M | 216.90M | 493.60M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
